Recent research suggests that a new approach could help even patients with advanced forms of fatty liver disease.

SGLT-2 inhibitors, compared with DPP-4 inhibitors, were associated with a lower risk for liver cirrhosis among patients with type 2 diabetes. Sodium-glucose cotransporter 2 (SGLT-2) inhibitors ...

Weight loss surgery can prevent people with obesity and fatty liver ... cirrhosis and obesity.” Metabolic dysfunction-associated steatohepatitis (MASH) is the most common form of chronic liver disease ...

6, 2025 — The research found that heavy drinkers with either diabetes ... Risk of Developing Complications of Liver Disease in Patients With Cirrhosis and Obesity Jan. 27, 2025 — A study ...

A silent epidemic is sweeping the globe and now affects billions. Discover the horrifying truth about a silent killer health ...

Primary Biliary Cholangitis Clinical Trial Pipeline Pharmaceutical companies are advancing the Primary Biliary Cholangitis treatment pipeli ...

A study by Keck Medicine of USC has found that alcohol consumption significantly increases the risk of advanced liver disease ...

The risk of serious liver damage from alcohol is more than twice as high for people with belly fat and diabetes, a new study found.

Devonian Health Group Inc. (“Devonian” or the “Company”) (TSXV: GSD; OTCQB: DVHGF), a clinical stage corporation focused on developing unique solution ...

Background and Aims: Neuropathy in association with chronic liver disease, including cirrhosis, is recognized; however, there are differences in the incidence and type of neuropathy reported.